Verus Capital Partners LLC Has $539,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Verus Capital Partners LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,032 shares of the medical equipment provider’s stock after acquiring an additional 38 shares during the period. Verus Capital Partners LLC’s holdings in Intuitive Surgical were worth $539,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of ISRG. Linscomb Wealth Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $270,000. QRG Capital Management Inc. boosted its holdings in shares of Intuitive Surgical by 2.1% in the fourth quarter. QRG Capital Management Inc. now owns 72,842 shares of the medical equipment provider’s stock valued at $38,020,000 after buying an additional 1,532 shares during the period. Versor Investments LP bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $248,000. Proficio Capital Partners LLC increased its position in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares in the last quarter. Finally, Kovack Advisors Inc. raised its holdings in shares of Intuitive Surgical by 21.5% during the fourth quarter. Kovack Advisors Inc. now owns 1,686 shares of the medical equipment provider’s stock worth $880,000 after acquiring an additional 298 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,077 shares of company stock worth $4,620,025 over the last three months. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $573.15 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market cap of $204.14 billion, a PE ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39. The firm has a 50-day moving average of $569.87 and a 200-day moving average of $528.64.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on ISRG shares. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.